BIIB vs FBK · P/E 21, rev $9.89B vs P/E 17, rev $454.8M
Biogen Inc (BIIB) versus FB Financial Corp (FBK) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
FB Financial Corp (FBK) is a banks - regional company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported FBK revenue for 2026-06-30 was $454.8M. Net income was $116.2M. FBK currently screens at market cap $2.57B and trailing P/E 17.4.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. FBK currently screens at market cap $2.57B and trailing P/E 17.4.
Not investment advice. Open the BIIB and FBK stock pages for the full models.
Not investment advice.